Replies to post #18007 on Cytodyn Inc (CYDY)

[BlackDoggie]

I know you didn't address this post to me, but...

Why would you need an exit strategy just because a R/S is approved? Because it will be approved. Just like it has been a shareholder-approved option for the board for the last several years.

Success or failure of the company - and therefore the stock price - is dependent on trial results and the ability of management to effectively message and leverage those results. Not an accounting move which, if properly applied, could open up this investment to institutional investors and a broader array of retail investors.

I don't understand everyone on this board, and others, that think that a R/S is a death sentence for a company with legitimate future prospects. I guess I shouldn't insinuate that you believe this, but your question about an exit strategy certainly begs that belief.

[buckysherm]

Exit ? If anything Buy more after the split. Don't want to be on the sidelines when PE is announced.

[gestalt2]

Why exit? does the science of pro 140 not work with a RS? is HIV become an non-existent problem with a RS?

I understand that many believe and have a long list of examples of when a RS caused nothing but a dropping SP. However, a RS typically is used for a company to stay in a market they may fall off of because of fundamental problems. That is not the case with CYDY as far as we know. Being on the otc has been a major problem for the past couple years and mgmt is solving it with a RS because an organic SP rise has been impossible on the otc. Can you think of a good reason that being on the otc is better? Which would you rather have, the ability to short and allow larger institutional buyers to invest or no institutional buyers and less shorting? More liquidity and exposure to a real market is always better.

[misiu143]

Personally I will exit only if results are not what I expect , otherwise I am here until BO.